资讯
A National Institutes of Health (NIH)-supported clinical trial has found that the outcome of treating complicated ...
A study published by JAMA Aug. 13 found that a two-dose antibiotic treatment could be just as effective as traditional ...
10 小时on MSN
Antibiotic use likely fueled the rise of a 'superbug' in NZ—genomics offers a defense ...
After a routine C-section at an Auckland hospital, a mother developed severe pain and what seemed like postnatal fatigue. It ...
A recent randomized clinical trial has found that dalbavancin, a long-acting lipoglycopeptide antibiotic, does not provide ...
The results of a randomized clinical trial suggest that patients with serious bloodstream infections caused by Staphylococcus ...
5 天
MedPage Today on MSNDalbavancin No Better Than Standard Therapy for Complicated S. Aureus Bacteremia
Among 200 patients, the probability of a more desirable day-70 outcome with two doses of intravenous dalbavancin versus 4 to ...
Airplane bathrooms aren’t exactly the most pleasant, comfortable, or even hygienic experiences. But their sheer number of ...
3 天
HealthDay on MSNDalbavancin Noninferior to Standard Therapy for Complicated S. Aureus Bacteremia
Dalbavancin is not superior to standard therapy for adults with complicated Staphylococcus aureus bacteremia, but clinical ...
Researchers have found an unexpected ally in the fight against superbugs: the fungi living right on your skin. In a discovery ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果